Semaglutide structure
Semaglutide
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
Find 61 Related Holders
MSN LIFE SCIENCES PRIVATE LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
AMBIO INC
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
FDC LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
PIRAMAL PHARMA LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
PolyPeptide SA
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
APICORE LLC
United States
United States
API Registration Country
API Active
-
Founded in:
2003-12-10 00:00:00 -
Country:
United States -
Address:
East Brunswick
BIOCON LTD
United Kingdom
United Kingdom
API Registration Country
API Active
-
Founded in:
2018-11-30 00:00:00 -
Country:
United Kingdom -
Address:
Torton Grove Torton Lane, Torton, Kidderminster, Worcestershire, United Kingdom, DY11 7SG
Bachem AG
Switzerland
Switzerland
API Registration Country
API Active
-
Country:
Switzerland -
Address:
Hauptstrasse 144, 4416 Bubendorf -
Email:
DR. REDDYS LABORATORIES LTD.
Philippines
Philippines
API Registration Country
API Active
-
Founded in:
2008-04-09 00:00:00 -
Country:
Philippines
TAPI NL B.V.
France
France
API Registration Country
API Active
-
Founded in:
2025-02-04 00:00:00 -
Country:
France -
Address:
55 Piet Heinkade 1019GM Amsterdam PAYS-BAS -
Email:
Recommended Suppliers of Semaglutide
-
Dingwang Technology (Wuhan) Co., Ltd.
CN1 YR
Contact Supplier -
NATURE INDUSTRIAL LIMITED
HK1 YR
Contact Supplier -
Horwats Biotech
CN1 YR
Contact Supplier -
SYS Pharma Corp.
CN1 YR
Contact Supplier -
Shenzhen Jipeptide Biotechnology Co.,Ltd
CN1 YR
Contact Supplier